Company Name
Hebei Changshan Biochemical Pharmaceutical Co.,Ltd.
Year of Establishment
2000
Annual Turnover(USD)
Other
Company Introduction
Our company is a leading enterprise specialized in developing and manufacturing Mucopolysaccharide bulk drugs (e.g. heparin sodium, heparinoid), preparation formulation and Sodium hyaluronate. GMP/COS certificate is available for Heparin sodium. DMF is under doing. Our high quality products and good service win a high reputation in the market. It is a great pleasure to build a nice cooperation with the interested company. Warmly welcome to contact us at any time.
Main Competitive Advantages
Brand Name,International Approvals/Standards,Production Capacity,Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service,
Milestone
2000 CSBIO was founded
2004 Granted China MA for Heparin Sodium Injection
2006 Granted MA for LMWH Calcium Injection in China
2008 Granted CEP certificate for Heparin Sodium API
2009 Passed French authority audit
2011 Listed in Shenzhen Stock Exchange Passed FDA unanounced inspection with no 483
2012 Acquisition of Changshan Biochemical Pharma(Jiangsu) Passed Germany authority audit
2014 Moving to current new manufacturing site Granted MA for Dalteparin SOdium Injection in China
2015 All Heparin APIs got EU GMP The 2nd time passed FDA inspection with no 483
2016 The 3rd time passed FDA unanounced inspection with no 483 Granted MA for Nadroparin Calcium Injection in China Granted MA for Sidenafil tablets in China
2017 Heparin API Passed Korean and Turkish authority audit
2018 Heparin Enoxaparin Sodium API Passed Argentina audit Heparin Sodium API passed Ukrain audit Heparin Sodium Injection (amboul) granded China GMP
2019 Enoxaparin sodium API & FDF got China GMP